Biohaven (BHVN) Change in Accured Expenses (2021 - 2026)

Biohaven has disclosed Change in Accured Expenses across 6 years of filings, most recently posting -$64.4 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$64.4 million, down 2415.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$63.0 million (down 3880.55% YoY), and the FY2025 annual result was $4.2 million, down 47.73% from the prior year.
• Change in Accured Expenses came in at -$64.4 million for Q1 2026 at Biohaven, down from -$12.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $33.1 million in Q2 2022 to a low of -$64.4 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is $2.8 million (2025), against an average of -$3.1 million.
• Across the five-year window, Change in Accured Expenses surged 222.96% in 2025 and slumped 2415.38% in 2026, its largest moves.
• Biohaven's Change in Accured Expenses stood at $18.7 million in 2022, then slumped by 172.34% to -$13.5 million in 2023, then climbed by 6.61% to -$12.6 million in 2024, then slipped by 1.26% to -$12.8 million in 2025, then slumped by 403.55% to -$64.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$64.4 million (Q1 2026), -$12.8 million (Q4 2025), and -$7.4 million (Q3 2025), per Business Quant data.